Effects of undernutrition on opportunistic infections among adults living with HIV on ART in Northwest Ethiopia: Using inverse-probability weighting

Animut Alebel; Daniel Demant; Pammla Petrucka; David Sibbritt

doi:10.1371/journal.pone.0264843

Abstract

Background

Opportunistic infections (OIs) are the leading causes of hospitalization, morbidity, and mortality (accounting for 94.1% of all deaths) in people living with human immunodeficiency virus (PLHIV). Despite evidence suggested that undernutrition significantly increases the risk of OIs in PLHIV, to our knowledge, no study has examined the actual effects of undernutrition on OIs in this population, particularly in low-income countries. Thus, this study examined the effects of undernutrition on OIs in adults living with HIV receiving antiretroviral therapy (ART).

Methods

We conducted a retrospective cohort study among 841adults living with HIV receiving ART between June 2014 and June 2020 at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia. Study participants were selected using a simple random sampling technique. Data from participants’ medical records were extracted using a project-specific data extraction checklist. The Kaplan Meier survival curve estimated the OIs free survival time. The effects of undernutrition on time to develop OIs was estimated using inverse-probability weighting. Finally, regression coefficients with 95% confidence intervals (95% CIs) were reported, with a statistical significance of p < 0.05.

Results

Of 841 study participants, 262 (31.2%) developed OIs, and the overall incidence rate was 16.7 (95% CI: 14.8, 18.8) per 100 person-years. The incWidence of OIs in undernourished participants (21/100 person-years, 95% CI: 17.8, 27.4) was higher than well-nourished participants (15.0/100 person-years, 95% CI: 12.9, 17.4). When everyone in the population of interest is well-nourished, average time to develop OIs is estimated as 26.5 (coefficient: 26.5, 95% CI: 20.6, 32.4, p < 0.001) months. When everyone in the population of interest is undernourished, average time to develop OIs is estimated as 17.7 (95% CI: 12.8, 22.6) months. However, when everyone is undernourished, average time to develop OIs decreases by 8.8 (coefficient: -8.8, 95% CI: -16.6, -1.0, p = 0.026) months. Lastly, exposure to undernourishment (intervention) (ratio of average treatment effects to well-nourished potential outcome means in this study was a 32.5% reduction in OIs among adults living with HIV on ART.

Conclusion

We found that undernutrition significantly shortened time to develop OIs in adults living with HIV. This implies that the occurrence of OIs in this vulnerable population can be improved through different cost-effective nutritional interventions, such as routine nutritional assessments and education.

Citation: Alebel A, Demant D, Petrucka P, Sibbritt D (2022) Effects of undernutrition on opportunistic infections among adults living with HIV on ART in Northwest Ethiopia: Using inverse-probability weighting. PLoS ONE 17(3): e0264843. https://doi.org/10.1371/journal.pone.0264843

Editor: Zelalem Nigussie Azene, University of Gondar, ETHIOPIA

Received: September 7, 2021; Accepted: February 17, 2022; Published: March 7, 2022

Copyright: © 2022 Alebel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting information files.

Funding: The author(s) received no specific funding for this work.

Competing interests: The authors have declared that no competing interests exist.

Abbreviations: AIDS, Acquired Immunodeficiency Syndrome; ALHIV, Adults living with HIV; ART, Antiretroviral Therapy; BMI, Body mass Index; CI, Confidence Interval; CPT, Cotrimoxazole Preventive Therapy; DMCSH, Debre Markos Comprehensive Specialized Hospital; HAART, Highly Active Antiretroviral Treatment; HIV, Human Immunodeficiency Virus; IPT, Isoniazid Preventive Therapy; IPW, Inverse-Probability Weighting; LMICs, Low and Middle-income Countries; OIs, Opportunistic Infections; PLHIV, People Living with Human Immunodeficiency Virus; SSA, Sub-Saharan Africa; TB, Tuberculosis; WHO, World Health Organization

Introduction

Opportunistic infections (OIs) are illnesses frequently occurring in people with weakened immune systems, such as those infected with human immunodeficiency virus (HIV) [1]. Although OIs have reduced significantly with the introduction of antiretroviral therapy (ART), they remain the leading cause of hospitalization, morbidity, and mortality (94.1% of all deaths) in people living with HIV (PLHIV) [2, 3]. OIs reduce quality of life, accelerate progression from HIV to acquired immunodeficiency syndrome (AIDS)-defining conditions, increase healthcare system burden, and lead to treatment failure [4–6]. Occurrence/recurrence of OIs and disease progression from HIV to AIDS are strongly influenced by malnutrition [7].

Although malnutrition includes both undernutrition and overnutrition, it commonly refers to undernutrition and related complications in low and middle-income countries (LMICs) [8]. Undernutrition is inadequate energy and nutrient intake to meet an individual’s needs for maintaining health [9]. There is a complex relationship between malnutrition and HIV [10]. PLHIV are at higher risk of malnutrition due to reduced oral intake, increased metabolic requirements, and decreased absorption of nutrients [11]. Reduced oral intake may result from oral thrush, oesophageal candidiasis, depression, or anorexia [12]. Fever increases nutritional requirements as it increases the body’s use of nutrients [13]. Furthermore, HIV-associated intestinal mucosal damage and diarrhoea can decrease nutrient absorption [14]. The relationship between malnutrition and OIs in PLHIV is also bidirectional. Studies from LMICs found undernutrition significantly increases risk of developing OIs in PLHIV [7, 15, 16]. OIs can increase risk of malnutrition by reducing nutrient absorption (e.g., intestinal parasites), reducing food intake (oesophageal candidiasis; oral thrush), as well as causing anorexia or increasing nutritional requirements (tuberculosis) [10, 11, 14].

Recent Ethiopian ART guidelines recommended interventions to prevent OIs, including exposure reduction (personal and environmental hygiene and safe sexual practices), provision of chemoprophylaxis (co-trimoxazole preventive therapy (CPT) and isoniazid preventive therapy (IPT)), immunizations, and provision of highly active antiretroviral therapy (HAART) [17]. Despite HAART is effective in reducing OIs in PLHIV, not all patients responded to the therapy equally [4]. Some patients experience a slow recovery of immune function, resulting in a continued high risk of OI-related morbidity and mortality. Inadequate immune response may be associated with malnutrition as the leading cause of immunodeficiency worldwide [10].

Although there are several studies on the association between undernutrition and TB among this population in LMICs [18, 19], to our knowledge, no study has examined the actual effect of undernutrition on OIs using a propensity score analysis. While randomized controlled trials (RCTs) are the gold standard for examining effects of treatment on outcomes, an RCT is not feasible on this topic due to ethical issues. In addition, we previously conducted a systematic review on this and found three significant gaps in the current body of literature [7]. Firstly, almost all studies included in our review on OIs focused on the association between undernutrition and TB, but little attention has been paid to the impact of undernutrition on other OIs. Secondly, most of the included studies used cox-regression to determine the association between undernutrition and TB instead of treatment effect analysis. Thirdly, although all studies attempted to control confounding variables using multivariable analysis, none of them used treatment effects analysis to show the actual effect of undernutrition on OIs. Thus, we conducted an observational study, examining effects of undernutrition on time to develop OIs using a propensity score analysis. Findings may assist clinicians in designing effective and efficient nutritional interventions to improve overall outcomes of PLHIV with malnutrition. Furthermore, findings provide insights to consider for a particular treatment option for managing OIs in malnourished adults living with HIV (ALHIV).

Methods

Study design, period, and setting

This institution-based retrospective cohort study used secondary data extracted from medical records of adult patients attending chronic HIV care at Debre Markos Comprehensive Specialized Hospital (DMSCH) between June 2014 and June 2020. DMCSH is the only referral hospital in East Gojjam Zone. The hospital started providing HIV care and ART services in 2005 with 1,209 PLHIV having ART initiated between June 2014 and June 2020 of which 1,177 (97.4%) were aged ≥ 15 years (adults).

HIV care provision in the ART clinic

Current Ethiopian ART guidelines state that all HIV-positive adults are eligible to start ART immediately, irrespective of WHO clinical disease staging and CD4 cell counts [17]. Activities provided by a team of physicians and nurses on the initial visit include, as necessary and available, patient counselling, co-trimoxazole preventive therapy (CPT), treatment of OIs, management of co-morbidities and referrals, as well as continuation of ART for transfer-ins. Laboratory tests at initial visit include baseline CD4 counts, complete blood count, alanine transaminase, and creatinine, cryptococcal antigen, Gene Xpert test if presumptive TB, pregnancy test, and other indicated tests. Follow-up appointments were scheduled (two weeks post-first visit) and then every month for the next three months. After four months, patients attend every two months for the next two months [17]. After six months, appointments at three-month intervals are scheduled for, as necessary, refilling ART and other mediations, managing drug toxicities, treating OIs, providing ART drug adherence support, referring to other services, and setting a next appointment.

Study population

All ALHIV who started ART at DMCSH within the study period and received ART for at least one month were eligible. ALHIV who had (I) transferred to DMCSH without baseline information, (II) unrecorded date of outcome of interest (OIs), and (III) pregnant women were excluded (as nutritional assessment differs from other ALHIV and their charts were not available) [20].

Sample size estimation and sampling

The minimum required sample size was estimated using an independent cohort study formula and calculated using Open Epi Version 3 [21]. Parameters used to estimate our sample size were α of 5%; power of 80%; Z_α/2 of 1.96; P₀ of 19%; P₁ of 27%; and r of 1:1. The sample size of 802 was based on a previous Ethiopian study [22], with an assumed 10% chart incompleteness yielding a final sample of 892. Through simple random sampling 892 records were selected from the eligible 1,177 ALHIV meeting inclusion criteria. Of these, 51 were excluded because of transferred in without baseline information (n = 21), pregnancy (n = 20), and unrecorded outcome date (n = 10). The final sample consisted of 841 records.

Data collection procedures

Project-specific standardized data extraction tools were based on current Ethiopian ART entry and follow-up forms to maintain data quality [17]. These tools had three main components (i.e., sociodemographics, clinical and laboratory characteristics, and medications including ART). Sociodemographics included sex, age, educational level, residence, marital status, occupation, disclosure of HIV status, and family size. Clinical and laboratory characteristics included OIs, baseline weight and height, CD4 cell counts, WHO clinical disease staging, Hgb level, and functional status. Medication-related characteristics included baseline ART regimen, adherence, regimen changes, and treatment failure, taking CPT, and isoniazid preventive therapy (IPT). First month measurements post-ART initiation were considered baseline data. The nutritional status of study participants was assessed using body mass index (BMI). First, anthropometric measurements (height and weight) were extracted from patients’ charts to determine their nutritional status (BMI). Second, BMI was calculated by dividing weight in kilograms by the height in meters squared (kg/m²). Finally, the study participants were classified as undernourished and well-nourished. Two epidemiologists specialized in HIV who currently working at DMCSH were recruited as data collectors with a biostatistician providing data collection supervision.

Study variables

The dependent variable was time to develop new OIs after ART initiation. Participants either lost to follow-up, those who died or were still alive at the end of the follow-up, but did not develop OIs, were classified as censored. Follow-up time was calculated in months from the date of ART initiation until the date of events (OIs) or censoring (other than events). The exposure variable was nutritional status (undernourished vs well-nourished). Three main covariate (confounders) classifications were sociodemographic, clinical/laboratory, and ART and other medication-related variables (see data collection).

Operational definitions

According to the Ethiopian ART guidelines, the most common OIs are: herpes zoster, bacterial pneumonia, pulmonary and extra-pulmonary TB, oral and oesophageal candidiasis, mouth ulcer, diarrhea, pneumocystis pneumonia, toxoplasmosis, cryptococcal meningitis, non-Hodgkin’s lymphoma, Kaposi’s sarcoma, cervical cancer, and others [17].

Undernutrition is defined as a BMI of less than 18.5 kg/m². The severity of undernutrition was classified as severe (BMI < 16 kg/m²), moderate (BMI: 16–16.99 kg/m²), and mild (BMI: 17–18.48 kg/m²) [23]. Undernourished (BMI < 18.5 kg/m²) participants were the exposed (treatment) group.

ART adherence was classified as good, fair, or poor, calculated from the total monthly dose of ART drugs (n = 60). Good is compliance equal to or greater than 95% or ≤ 3 missed doses per month; fair 85–94% compliance or between 4 and 8 missing doses per month; and poor as less than 85% compliance or ≥ 9 missed doses per month [17].

The WHO divided adult immune status into four HIV-related immunodeficiency zones: no significant (CD4 > 500 cells/mm³), mild (CD4: 350−499 cells/mm³), advanced (CD4: 200−349 cells/mm³), and severe (CD4<200 cells/mm³) [24].

Loss to follow-up (LTFU) was defined as ALHIV missing an ART appointment for at least one month [17].

Missing data handling

One-quarter (24.4%, n = 205) of CD4 cell counts and 5.9% (n = 50) of haemoglobin (Hgb) levels were unavailable from records. Multiple imputation (MI) was used for these variables after checking the pattern and mechanisms of missing values. Little’s MCAR test was conducted to check whether the values are missing at random or not [25]. The final imputation was performed using a multivariate normal imputation model. Variables included were sex, residence, WHO clinical disease staging, ART adherence, nutritional status, OIs, CPT, and IPT. Lastly, distributions in the observed, imputed, and completed data (multiple imputation diagnostic test) were assessed using the diagnostic plots for multiple imputation.

Statistical analysis

The Kaplan-Meier survival curve was constructed to estimate the OIs free survival time in undernourished (exposed) and well-nourished (non-exposed) participants. The survival curves were compared using a generalized log-rank test. As we used data from the observational study to determine treatment effects on outcomes, propensity scores were generated to reduce or eliminate confounding effects [26]. The propensity scores were constructed and assessed in five steps, as presented below [27].

Step 1: Covariate selection: Nine covariates (i.e., sex, residence, WHO clinical staging, CD4 cell count, Hgb, CPT, IPT, HIV status disclosure, and ART adherence) were identified from previous literature [28–33].
Step 2: Propensity score estimation: The propensity scores for all nine covariates were generated using a logistic regression model, in which nutritional status was regressed on these covariates. As our aim was estimating treatment effects using survival data, we employed the Log-normal model (with the least Akaike information criterion and Bayesian information criterion) for censoring time.
Step 3: Propensity score method selection: To adjust observed differences in baseline characteristics between exposed and non-exposed groups, we employed inverse-probability weighting (IPW) [26]. This estimator was used for two reasons. Firstly, we intended to model treatment assignment (exposure) rather than the outcome. Secondly, our study had 579 (68.8%) censored observations. When there is censoring, IPW estimator calculated the weights from two models, one for censoring time and one for treatment assignment.
Step 4: Balance assessment: Common assumptions to use treatment-effects estimators (i.e., conditional independence, sufficient overlap, and correct adjustment for censoring) were assessed using overlap plots (positivity assumption) and covariate balance tests. The overlap assumption requires propensity score distribution for each treatment level greater than zero but less than one [34]. Covariate balance was evaluated by comparing standardized differences and variance ratios before and after weighting. Weighted standardized differences close to zero indicate balanced data, as a high of 0.25 (25%). is acceptable [35]. Rubin suggested covariates are considered balanced if weighted variance ratios are between 0.8 and 1.25 [36].
Step 5: Treatment effects estimation: The average treatment effects (ATE) of undernutrition on time to develop OIs was estimated using an IPW. Regression coefficients with 95% confidence intervals (95% CIs) were reported, with a statistical significance of p < 0.05. All statistical analyses were performed using Stata^™ Version 16.

Ethical considerations

Ethical approvals and permissions were granted from the DMCSH Medical Director’s Office, the University of Technology Sydney Medical Research Ethics Committee (ETH20-5044), and the Amhara Regional Public Health Research Ethics Review Committee (Ref. no: 816). As the study was based on existing medical records of PLHIV, participants’ verbal or written informed consent was not feasible, and a waiver of consent was granted. Data were completely de-identifiable to the authors, as the data abstraction tool did not include participants’ unique ART numbers and names. The collected data was stored and locked in a separate room before data entry.

Results

Sociodemographic characteristics of the cohort

Of the 841 study participants, 21.6% (n = 182) were from rural areas, and 59.0% (n = 496) were female. More than half (n = 467; 55.5%) of the participants were between 15 and 34 years old, with a median age of 32 years (IQR: 26–40). One-quarter (n = 214; 25.5%) of participants were divorced, 69.6% (n = 585) were able to read and write, and 21.4% (n = 180) were employed. Almost one-third (n = 276; 32.8%) did not disclose their HIV status to their sexual partners or family members and 55.4% (n = 470) were from families with fewer than three people (see Table 1).

Download:

Table 1. Baseline sociodemographic characteristics of adults living with HIV on ART at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia (n = 841).

https://doi.org/10.1371/journal.pone.0264843.t001

Clinical characteristics of participants

At ART initiation, 39.7% (n = 334) of participants presented with OIs, and 26.5% (n = 223) were undernourished. Of these 223 undernourished participants, 116 (52%) had OIs. Only 16.5% (n = 139) of participants were classified as bedridden or ambulatory functional status. Nearly one-third (n = 271; 32.2%) of participants had severe immunodeficiency, with a median CD4 count of 324.3 (IQR = 158–499) cells/mm³ with 44.0% (n = 370) classified as WHO clinical stage I. Forty-three (5.1%) participants had baseline anaemia, with mean Hgb of all participants at 13.8 (SD ±2.4) g/dl. More than half (n = 464; 55.2%) of participants started ART through the test and treat approach, and most (n = 757; 90.0%) began Efavirenz-based ART. Three-quarters (n = 634; 75.4%) of participants showed good compliance with ART, while about one-third (31.5%; n = 265) experienced a change in baseline ART regimen. Furthermore, 73.0% (n = 614) and 62.8% (n = 528) of the participants took CPT and IPT, respectively. ART treatment failure throughout follow-up was seen in 23 (2.7%) participants (see Table 2).

Download:

Table 2. Clinical characteristics of participants at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia (n = 841).

https://doi.org/10.1371/journal.pone.0264843.t002

Incidence of opportunistic infections

Participants were followed retrospectively for between one month and 72 months, with total follow-up time being 18,855 person-months. At the end of follow-up, 262 (31.2%) participants developed OIs, and overall incidence rate was 16.7 (95% CI: 14.8, 18.8) per 100 person-years of observation. Of the OIs, tuberculosis (TB) (n = 42; 15%), sexually transmitted infections (STIs) (n = 39; 14.4%), and bacterial pneumonia (n = 32; 11.8%) were most common (see Table 3). Approximately 160 (61.0%) cases of OIs occurred in the first year of follow-up. The incidence of OIs in undernourished (exposed) adults was 21 per 100 person-years (95% CI: 17.8, 27.4), while the incidence of OIs in well-nourished (non-exposed) adults was 15.0 per 100 person-years (95% CI: 12.9, 17.4). Undernourished participants’ OIs-free survival time was significantly shorter than well-nourished participants (log-rank test, p = 0.004; see Fig 1).

Download:

Fig 1. Kaplan-Meier survival curves to compare OIs free survival time between undernourished and well-nourished adults living with HIV on ART at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia, 2021.

https://doi.org/10.1371/journal.pone.0264843.g001

Download:

Table 3. Common opportunistic infections during follow-up in adults living with HIV on ART at Debre Markos Comprehensive Specialized, Northwest Ethiopia, 2021.

https://doi.org/10.1371/journal.pone.0264843.t003

Checking balance on propensity scores

After generating prosperity scores for nine covariates, overlap plots were used to evaluate the hypothesis of sufficient overlap (see Fig 2). Although there is no specific statistical test to verify the overlap assumption, predicted treatment probabilities were summarised, with the minimum and maximum predicted propensity scores for undernourished participants being 0.13 and 0.7, respectively. There is no evidence that the overlap assumption is violated.

Download:

Fig 2. Propensity score distribution for overlap assumption among adults living with HIV on ART at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia, 2021.

https://doi.org/10.1371/journal.pone.0264843.g002

Checking balance on covariates

The standardized differences of covariates ranged from 1.0% to 46.2% before weighting and 0.1% to 2.9% after weighting. Variance ratios of covariates ranged from 0.7 to 2.7 before weighting and ranged from 0.9 to 1.0 after weighting. An overidentification test was conducted for further verification. The test results (χ2 = 11.6, p = 0.313) confirmed there is no evidence to reject the null hypothesis (H₀ = covariates are balanced), implying the specified treatment model balanced the covariates.

Effect of undernutrition on opportunistic infections

When everyone in the population of interest is well-nourished, average time to develop OIs is estimated as 26.5 (95% CI: 20.6, 32.4) months. When everyone in the population of interest is undernourished, average time to develop OIs is estimated as 17.7 (95% CI: 12.8, 22.6) months. When everyone is undernourished, average time to develop OIs decreases by 8.8 (95% CI: -16.6, -1.0) months (see Table 3). Lastly, effectiveness of exposure to undernourishment (intervention) (ratio of ATE to well-nourished potential outcome means [POM]) in this study was a 32.5% reduction in OIs (see Table 4).

Download:

Table 4. The effect of undernutrition on the time to develop OIs in adults living with HIV on ART at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia.

https://doi.org/10.1371/journal.pone.0264843.t004

Discussion

Although OIs have significantly reduced since the introduction of HAART, they remain the leading cause of premature deaths, especially in undernourished PLHIV [4, 16]. This institution-based retrospective cohort study examined effects of undernutrition on OIs in ALHIV receiving ART. To the best of our knowledge, this is the first study investigating the effects of undernutrition on OIs in this population using a propensity score analysis for time-to-event data. During follow-up, nearly a third (31.2%) of participants developed OIs and TB at 15% was the most common. Besides, the incidence of OIs in undernourished (21 per 100 person-years: 95% CI: 17.8, 27.4) ALHIV on ART is higher than their well-nourished counterparts (15.0 per 100 person-years: 95% CI: 12.9, 17.4). This study also found that undernutrition significantly shortened time to develop OIs in ALHIV receiving ART. When everyone is undernourished, the average time to develop OIs decreases by 8.8 months.

Although we did not find similar studies that used propensity score analysis to examine the effects of undernutrition on OIs, we compared our findings with studies reporting the association between undernutrition and OIs. Our finding is consistent with a meta-analysis in sub-Saharan Africa conducted by our team, which found that the risk of developing TB in undernourished ALHIV is twice that of well-nourished ALHIV [7]. Additionally, this result is comparable to a cross-sectional study conducted in Ethiopia that reported a significant association between undernutrition and parasitic infections [37]. Furthermore, a Zambian prospective cohort has also documented that the occurrence of AIDS-defining illness was strongly associated with moderate wasting [38].

The causal relationship between malnutrition and OIs can be explained in different ways, as malnutrition is one of the main causes of immunodeficiency worldwide [10]. For example, it causes nutritional-acquired immune dysfunction and increases host susceptibility to infection [39]. Undernutrition also weakens the immune system through atrophy of the thymus, spleen, lymph nodes, and reduced cell-mediated immunity [40]. An essential amino acid deficiency also impairs the synthesis of proteins responsible for producing cytokines secreted by lymphocytes, macrophages, and other cells of the body during the acute inflammatory response [41]. These collectively impair the patient’s ability to fight and recover from infections.

The indirect effects of undernutrition on the occurrence of OIs can be explained in various mechanisms. In this regard, there is some evidence that malnutrition is significantly associated with poor adherence to ART [42, 43]. It is well known that although ART dramatically reduces the occurrence and recurrence of OIs, it is only effective if the patient takes its medication regularly [17]. Alternatively, our finding could be justified by the impact of undernutrition on treatment failure, as undernutrition is a strong predictor of treatment failure [44–46]. Lastly, poor nutritional status was also cited as a common reason for the discontinuation of ART and loss to follow-up [47–52]. One qualitative study showed patients believe that ART without adequate food might be ineffective or even harmful, explaining poor ART adherence [53]. Lastly, patients may forget or are unable to take ART while working or searching for food [54].

During follow-up, almost one-third (31.2%) of participants had OIs, with an incidence of 16.7 (95% CI: 14.8, 18.8) per 100 person-years of observation. This finding is higher than a Ugandan study (5.9 per 100 person-years of observation) [3]. The variation could be due to the difference in follow-up period. We followed participants retrospectively for almost six years, while the follow-up period for the Ugandan study was ten years. As length of follow-up increased, the number of years of follow-up for each person also increased. This can increase the denominator and decrease the overall incidence. In our study, approximately 61.0% of OIs occurred within the first year which is similar to the same time period in the Ugandan study at 74.1%. This reflects the shorter the follow-up period, the higher the incidence rate.

Regarding OI patterns, TB (15.5%), STIs (14.4%), bacterial pneumonia (11.8%), and diarrhoea (11.1%) were the most common. This finding is in line with a systematic review conducted in LMICs, which found oral candidiasis (19.1%), herpes zoster (9.4%), pulmonary TB (9.0%), and bacterial pneumonia (6.1%) are the most common OIs in ART-naïve people [4]. A similar pattern from a Ugandan study reported oral candidiasis (43.6%), tuberculosis (21.6%), herpes zoster (19.9%), and cryptococcal meningitis (4.6%) as the most common OIs [3]. Ethiopia bears one of the highest countries of TB and TB/HIV co-infection rates globally [55]. This trend is reflected in our study, where TB is the most common HIV-associated OI. The risk of developing TB in PLHIV is 20 times higher than in people without HIV [56].

Lastly, our study found that 61.0% of OIs occurred in the first year of follow-up. This finding is consistent with a study conducted in Uganda that showed 71.4% OIs happed in the first year [3]. Immune reconstitution inflammatory syndrome is prevalent between the first and third months of ART. It strongly increases the protective responses of the immune system, leading to a typical inflammatory condition, which increases the risk of developing OIs, especially cryptococcal and TB meningitis [57, 58]. This reflects patients must be closely monitored for the presence of OIs in the early phase of ART.

Strengths and limitations of the study

The strengths of this study are the longer follow-up period (6 years) and large sample size (n = 841), increasing precision. The data recording system for HIV-positive patients is standardized across Ethiopia, providing an opportunity to obtain comparably high-quality data. However, this study has limitations that must be taken into account while interpreting the results. Since we used secondary data, important variables that are likely to influence OIs, such as viral load, income level, eating habits, substance use, and micronutrient deficiency were unavailable. Moreover, although OIs can recur, treatment effect analysis cannot handle recurrent events (multiple-records). As a result, this study only estimated time to develop the second OIs. The overall magnitude of OIs may be underestimated due to limited diagnostic options in resource-limited settings.

Conclusion

We found that undernutrition significantly shortened time to develop OIs in ALHIV. This implies that the occurrence of OIs in this vulnerable population can be improved through different cost-effective nutritional interventions, such as routine nutritional assessments and education. The finding also highlights the need for appropriate nutritional support and monitoring along with ART. There is a need to strengthen counselling and appropriate dietary support based on the nutritional assessment at each visit by ALHIV receiving ART. A comprehensive approach is needed to improve nutritional status of PLHIV. As TB remains the main OI in this population, detection and treatment in PLHIV still requires special attention. The results of this study are also helpful for clinicians to consider alternative nutritional treatment options or may inform revisions to existing guidelines such as other nutritional assessments, counselling, and supports targeting people living with HIV who have OIs. Further intervention studies may assess the impact of nutritional interventions on the occurrence of OIs in PLHIV.

Supporting information

S1 File. Data set used for this study.

https://doi.org/10.1371/journal.pone.0264843.s001

(DTA)

Acknowledgments

The authors would like to thank the data collectors and their supervisor.

References

1. Centers for Disease Control and Prevention (CDC): AIDS and Opportunistic Infections https://www.cdc.gov/hiv/basics/livingwithhiv/opportunisticinfections.html accessed 03 July 2020. In.; Last updated August 2019.
2. Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ, et al: Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2015, 2(10):e438–444. pmid:26423651
- View Article
- PubMed/NCBI
- Google Scholar
3. Weissberg D, Mubiru F, Kambugu A, Fehr J, Kiragga A, von Braun A, et al: Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort. PLoS One 2018, 13(11):e0206796. pmid:30383836
- View Article
- PubMed/NCBI
- Google Scholar
4. Low A, Gavriilidis G, Larke N, MR BL, Drouin O, Stover J, et al: Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Clin Infect Dis 2016, 62(12):1595–1603. pmid:26951573
- View Article
- PubMed/NCBI
- Google Scholar
5. Ghiasvand H, Waye KM, Noroozi M, Harouni GG, Armoon B, Bayani A: Clinical determinants associated with quality of life for people who live with HIV/AIDS: A meta-analysis. BMC Health Services Research 2019, 19(1):768. pmid:31665007
- View Article
- PubMed/NCBI
- Google Scholar
6. Mulisa D, Tesfa M, Mullu Kassa G, Tolossa T: Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: Un-matched case control study. BMC Infectious Diseases 2019, 19(1):1024. pmid:31795955
- View Article
- PubMed/NCBI
- Google Scholar
7. Alebel A, Demant D, Petrucka P, Sibbritt D: Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infectious Diseases 2021, 21(1):1. pmid:33390160
- View Article
- PubMed/NCBI
- Google Scholar
8. Saunders J, Smith T: Malnutrition: causes and consequences. Clin Med (Lond) 2010, 10(6):624–627. pmid:21413492
- View Article
- PubMed/NCBI
- Google Scholar
9. Maleta K: Undernutrition. Malawi Medical Journal 2006, 18(4):189–205. pmid:27529011
- View Article
- PubMed/NCBI
- Google Scholar
10. Duggal S, Chugh TD, Duggal AK: HIV and malnutrition: Effects on immune system. Clin Dev Immunol 2012, 2012:784740–784740. pmid:22242039
- View Article
- PubMed/NCBI
- Google Scholar
11. Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb P: HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis 2009, 49(7):1096–1102. pmid:19725790
- View Article
- PubMed/NCBI
- Google Scholar
12. De Pee S, Semba RD: Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010, 31(4_suppl4):S313–S344.
- View Article
- Google Scholar
13. Childs CE, Calder PC, Miles EA: Diet and Immune Function. Nutrients 2019, 11(8). pmid:31426423
- View Article
- PubMed/NCBI
- Google Scholar
14. Sashindran VK, Thakur R: Malnutrition in HIV/AIDS: aetiopathogenesis. Nutrition and HIV/AIDS-Implication for Treatment, Prevention and Cure[series online] 2020.
15. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al: Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007, 21(6):713–719. pmid:17413692
- View Article
- PubMed/NCBI
- Google Scholar
16. Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M: Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. Journal of Acquired Immune Deficiency Syndromes 2011, 57(4):311–318. pmid:21423023
- View Article
- PubMed/NCBI
- Google Scholar
17. Ministry of Health Ethiopia: National Comprehensive HIV Prevention, Care and Treatment Training for Health care Providers. Addis Ababa, Ethiopia 2017.
18. Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ: Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: A retrospective cohort study BMC Infectious Diseases 2019, 19(1). pmid:30654753
- View Article
- PubMed/NCBI
- Google Scholar
19. Tiruneh G, Getahun A, Adeba E: Assessing the impact of Isoniazid Preventive Therapy (IPT) on tuberculosis incidence and predictors of tuberculosis among adult patients enrolled on ART in Nekemte Town, Western Ethiopia: A retrospective cohort study. Interdisciplinary Perspectives on Infectious Diseases 2019, 2019:1413427. pmid:31186628
- View Article
- PubMed/NCBI
- Google Scholar
20. Ververs MT, Antierens A, Sackl A, Staderini N, Captier V: Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context? PLoS Currents 2013, 5. pmid:23787989
- View Article
- PubMed/NCBI
- Google Scholar
21. Kelsey JL, Whittemore AS, Evans AS, Thompson WD: Methods in observational epidemiology: Monographs in Epidemiology and Biostatistics; 1996.
22. Teshale AB, Tsegaye AT, Wolde HF: Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling. PLoS One 2020, 15(1):e0227473. pmid:31978137
- View Article
- PubMed/NCBI
- Google Scholar
23. Purnell JQ: Definitions, Classification, and Epidemiology of Obesity. In: Endotext [Internet]. edn.: MDText. com, Inc.; 2018.
24. Garcia SAB, Guzman N: Acquired Immune Deficiency Syndrome CD4+ Count. In: StatPearls [Internet]. edn.: StatPearls Publishing; 2020.
25. Little RJ: A test of missing completely at random for multivariate data with missing values. Journal of the American statistical Association 1988, 83(404):1198–1202.
- View Article
- Google Scholar
26. Austin : An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res 2011, 46(3):399–424. pmid:21818162
- View Article
- PubMed/NCBI
- Google Scholar
27. Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, et al: Methods for constructing and assessing propensity scores. Health Services Research 2014, 49(5):1701–1720. pmid:24779867
- View Article
- PubMed/NCBI
- Google Scholar
28. Addis Alene K, Nega A, Wasie Taye B: Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infectious Diseases 2013, 13:292. pmid:23806088
- View Article
- PubMed/NCBI
- Google Scholar
29. Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, et al: Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS 2015, 29(11):1391–1399. pmid:26091295
- View Article
- PubMed/NCBI
- Google Scholar
30. Dereje N, Moges K, Nigatu Y, Holland R: Prevalence And predictors of opportunistic infections among HIV positive adults on antiretroviral therapy (On-ART) versus Pre-ART In Addis Ababa, Ethiopia: A comparative cross-sectional study. HIV/AIDS—Research and Palliative Care 2019, 11:229–237.
- View Article
- Google Scholar
31. Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A, et al: Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infectious Diseases 2019, 19(1):914. pmid:31664933
- View Article
- PubMed/NCBI
- Google Scholar
32. Temesgen B, Kibret GD, Alamirew NM, Melkamu MW, Hibstie YT, Petrucka P, et al: Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: A retrospective record review. BMC Public Health 2019, 19(1):1566. pmid:31771552
- View Article
- PubMed/NCBI
- Google Scholar
33. Solomon FB, Angore BN, Koyra HC, Tufa EG, Berheto TM, Admasu M: Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone Hospital: A retrospective study. BMC Research Notes 2018, 11(1):604. pmid:30126450
- View Article
- PubMed/NCBI
- Google Scholar
34. Ali MS, Prieto-Alhambra D, Lopes LC, Ramos D, Bispo N, Ichihara MY, et al: Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances. Frontirs in Pharmacology 2019, 10:973.
- View Article
- Google Scholar
35. Stuart EA, Lee BK, Leacy FP: Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. Journal of clinical epidemiology 2013, 66(8 Suppl):S84–S90.e81. pmid:23849158
- View Article
- PubMed/NCBI
- Google Scholar
36. Rubin DB: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Statistics in Medicine 2007, 26(1):20–36. pmid:17072897
- View Article
- PubMed/NCBI
- Google Scholar
37. Gedle D, Kumera G, Eshete T, Ketema K, Adugna H, Feyera F: Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia. Journal of Health, Population, and Nutrition 2017, 36(1):15. pmid:28506307
- View Article
- PubMed/NCBI
- Google Scholar
38. Chen YN, Wall KM, Fofana K, Navarro-Colorado C: Nutrition indicators as potential predictors of AIDS-defining illnesses among ARV-naïve HIVpositive adults in Kapiri Mposhi, Zambia 2008–2009. PLoS ONE 2019, 14(7).
- View Article
- Google Scholar
39. Katona P, Katona-Apte J: The interaction between nutrition and infection. Clin Infect Dis 2008, 46(10):1582–1588. pmid:18419494
- View Article
- PubMed/NCBI
- Google Scholar
40. Bourke CD, Berkley JA, Prendergast AJ: Immune Dysfunction as a Cause and Consequence of Malnutrition. Trends Immunol 2016, 37(6):386–398. pmid:27237815
- View Article
- PubMed/NCBI
- Google Scholar
41. Wan JM, Haw MP, Blackburn GL: Nutrition, immune function, and inflammation: an overview. Proc Nutr Soc 1989, 48(3):315–335. pmid:2515541
- View Article
- PubMed/NCBI
- Google Scholar
42. Berhe N, Tegabu D, Alemayehu M: Effect of nutritional factors on adherence to antiretroviral therapy among HIV-infected adults: A case control study in Northern Ethiopia. BMC Infectious Diseases 2013, 13:233. pmid:23701864
- View Article
- PubMed/NCBI
- Google Scholar
43. Young S, Wheeler AC, McCoy SI, Weiser SD: A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS and Behaviour 2014, 18 Suppl 5:S505–515. pmid:23842717
- View Article
- PubMed/NCBI
- Google Scholar
44. Babo YD, Alemie GA, Fentaye FW: Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PLoS One 2017, 12(11):e0187694. pmid:29095936
- View Article
- PubMed/NCBI
- Google Scholar
45. Ahmed M, Merga H, Jarso H: Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: A case-control study. BMC Infectious Diseases 2019, 19(1):305. pmid:30943903
- View Article
- PubMed/NCBI
- Google Scholar
46. Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS: Predictors of time to first line antiretroviral treatment failure among adult patients living with HIV in public health facilities of Arba Minch Town, Southern Ethiopia. Ethiopian Journal of Health Sciences 2019, 29(2):175–186. pmid:31011265
- View Article
- PubMed/NCBI
- Google Scholar
47. Bernard C, Balestre E, Coffie PA, Eholie SP, Messou E, Kwaghe V, et al: Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration. HIV AIDS (Auckl) 2018, 10:239–252. pmid:30532600
- View Article
- PubMed/NCBI
- Google Scholar
48. Kalinjuma AV, Glass TR, Weisser M, Myeya SJ, Kasuga B, Kisung’a Y, et al: Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania. Journal of the International AIDS Society 2020, 23(3):e25460. pmid:32128998
- View Article
- PubMed/NCBI
- Google Scholar
49. Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG, Yenit MK: Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: Retrospective follow up study. BMC Research Notes 2019, 12(1):111. pmid:30819236
- View Article
- PubMed/NCBI
- Google Scholar
50. Teshome W, Belayneh M, Moges M, Mekonnen E, Endrias M, Ayele S, et al: Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in south Ethiopia? A retrospective follow-up study. HIV AIDS (Auckl) 2015, 7:167–174.
- View Article
- Google Scholar
51. Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al: Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open 2013, 3(10):e003499. pmid:24163204
- View Article
- PubMed/NCBI
- Google Scholar
52. Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al: Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS One 2018, 13(1):e0188488. pmid:29373574
- View Article
- PubMed/NCBI
- Google Scholar
53. Tiruneh YM, Galárraga O, Genberg B, Wilson IB: Retention in Care among HIV-Infected Adults in Ethiopia, 2005–2011: A Mixed-Methods Study. PLoS One 2016, 11(6):e0156619. pmid:27272890
- View Article
- PubMed/NCBI
- Google Scholar
54. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR: Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One 2010, 5(4):e10340. pmid:20442769
- View Article
- PubMed/NCBI
- Google Scholar
55. World Health Organization: WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: https://cdn.who.int/media/docs/default-source/hq-tuberculosis/who_globalhbcliststb_2021-2025_backgrounddocument.pdf?sfvrsn=f6b854c2_9. 2021.
56. World Health Organisation: HIV-Associated Tuberculosis https://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet.pdf?ua=1. 2018.
57. Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, et al: Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 2014, 370(26):2487–2498. pmid:24963568
- View Article
- PubMed/NCBI
- Google Scholar
58. Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, et al: Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009, 51(2):130–134. pmid:19365271
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Centers for Disease Control and Prevention (CDC): AIDS and Opportunistic Infections https://www.cdc.gov/hiv/basics/livingwithhiv/opportunisticinfections.html accessed 03 July 2020. In.; Last updated August 2019.

[ref2] 2. Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ, et al: Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2015, 2(10):e438–444. pmid:26423651
View Article
PubMed/NCBI
Google Scholar

[3] View Article

[4] PubMed/NCBI

[5] Google Scholar

[ref3] 3. Weissberg D, Mubiru F, Kambugu A, Fehr J, Kiragga A, von Braun A, et al: Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort. PLoS One 2018, 13(11):e0206796. pmid:30383836
View Article
PubMed/NCBI
Google Scholar

[7] View Article

[8] PubMed/NCBI

[9] Google Scholar

[ref4] 4. Low A, Gavriilidis G, Larke N, MR BL, Drouin O, Stover J, et al: Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Clin Infect Dis 2016, 62(12):1595–1603. pmid:26951573
View Article
PubMed/NCBI
Google Scholar

[11] View Article

[12] PubMed/NCBI

[13] Google Scholar

[ref5] 5. Ghiasvand H, Waye KM, Noroozi M, Harouni GG, Armoon B, Bayani A: Clinical determinants associated with quality of life for people who live with HIV/AIDS: A meta-analysis. BMC Health Services Research 2019, 19(1):768. pmid:31665007
View Article
PubMed/NCBI
Google Scholar

[15] View Article

[16] PubMed/NCBI

[17] Google Scholar

[ref6] 6. Mulisa D, Tesfa M, Mullu Kassa G, Tolossa T: Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: Un-matched case control study. BMC Infectious Diseases 2019, 19(1):1024. pmid:31795955
View Article
PubMed/NCBI
Google Scholar

[19] View Article

[20] PubMed/NCBI

[21] Google Scholar

[ref7] 7. Alebel A, Demant D, Petrucka P, Sibbritt D: Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infectious Diseases 2021, 21(1):1. pmid:33390160
View Article
PubMed/NCBI
Google Scholar

[23] View Article

[24] PubMed/NCBI

[25] Google Scholar

[ref8] 8. Saunders J, Smith T: Malnutrition: causes and consequences. Clin Med (Lond) 2010, 10(6):624–627. pmid:21413492
View Article
PubMed/NCBI
Google Scholar

[27] View Article

[28] PubMed/NCBI

[29] Google Scholar

[ref9] 9. Maleta K: Undernutrition. Malawi Medical Journal 2006, 18(4):189–205. pmid:27529011
View Article
PubMed/NCBI
Google Scholar

[31] View Article

[32] PubMed/NCBI

[33] Google Scholar

[ref10] 10. Duggal S, Chugh TD, Duggal AK: HIV and malnutrition: Effects on immune system. Clin Dev Immunol 2012, 2012:784740–784740. pmid:22242039
View Article
PubMed/NCBI
Google Scholar

[35] View Article

[36] PubMed/NCBI

[37] Google Scholar

[ref11] 11. Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb P: HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis 2009, 49(7):1096–1102. pmid:19725790
View Article
PubMed/NCBI
Google Scholar

[39] View Article

[40] PubMed/NCBI

[41] Google Scholar

[ref12] 12. De Pee S, Semba RD: Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010, 31(4_suppl4):S313–S344.
View Article
Google Scholar

[43] View Article

[44] Google Scholar

[ref13] 13. Childs CE, Calder PC, Miles EA: Diet and Immune Function. Nutrients 2019, 11(8). pmid:31426423
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref14] 14. Sashindran VK, Thakur R: Malnutrition in HIV/AIDS: aetiopathogenesis. Nutrition and HIV/AIDS-Implication for Treatment, Prevention and Cure[series online] 2020.

[ref15] 15. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al: Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007, 21(6):713–719. pmid:17413692
View Article
PubMed/NCBI
Google Scholar

[51] View Article

[52] PubMed/NCBI

[53] Google Scholar

[ref16] 16. Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M: Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. Journal of Acquired Immune Deficiency Syndromes 2011, 57(4):311–318. pmid:21423023
View Article
PubMed/NCBI
Google Scholar

[55] View Article

[56] PubMed/NCBI

[57] Google Scholar

[ref17] 17. Ministry of Health Ethiopia: National Comprehensive HIV Prevention, Care and Treatment Training for Health care Providers. Addis Ababa, Ethiopia 2017.

[ref18] 18. Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ: Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: A retrospective cohort study BMC Infectious Diseases 2019, 19(1). pmid:30654753
View Article
PubMed/NCBI
Google Scholar

[60] View Article

[61] PubMed/NCBI

[62] Google Scholar

[ref19] 19. Tiruneh G, Getahun A, Adeba E: Assessing the impact of Isoniazid Preventive Therapy (IPT) on tuberculosis incidence and predictors of tuberculosis among adult patients enrolled on ART in Nekemte Town, Western Ethiopia: A retrospective cohort study. Interdisciplinary Perspectives on Infectious Diseases 2019, 2019:1413427. pmid:31186628
View Article
PubMed/NCBI
Google Scholar

[64] View Article

[65] PubMed/NCBI

[66] Google Scholar

[ref20] 20. Ververs MT, Antierens A, Sackl A, Staderini N, Captier V: Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context? PLoS Currents 2013, 5. pmid:23787989
View Article
PubMed/NCBI
Google Scholar

[68] View Article

[69] PubMed/NCBI

[70] Google Scholar

[ref21] 21. Kelsey JL, Whittemore AS, Evans AS, Thompson WD: Methods in observational epidemiology: Monographs in Epidemiology and Biostatistics; 1996.

[ref22] 22. Teshale AB, Tsegaye AT, Wolde HF: Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling. PLoS One 2020, 15(1):e0227473. pmid:31978137
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref23] 23. Purnell JQ: Definitions, Classification, and Epidemiology of Obesity. In: Endotext [Internet]. edn.: MDText. com, Inc.; 2018.

[ref24] 24. Garcia SAB, Guzman N: Acquired Immune Deficiency Syndrome CD4+ Count. In: StatPearls [Internet]. edn.: StatPearls Publishing; 2020.

[ref25] 25. Little RJ: A test of missing completely at random for multivariate data with missing values. Journal of the American statistical Association 1988, 83(404):1198–1202.
View Article
Google Scholar

[79] View Article

[80] Google Scholar

[ref26] 26. Austin : An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res 2011, 46(3):399–424. pmid:21818162
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref27] 27. Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, et al: Methods for constructing and assessing propensity scores. Health Services Research 2014, 49(5):1701–1720. pmid:24779867
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref28] 28. Addis Alene K, Nega A, Wasie Taye B: Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infectious Diseases 2013, 13:292. pmid:23806088
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref29] 29. Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, et al: Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS 2015, 29(11):1391–1399. pmid:26091295
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref30] 30. Dereje N, Moges K, Nigatu Y, Holland R: Prevalence And predictors of opportunistic infections among HIV positive adults on antiretroviral therapy (On-ART) versus Pre-ART In Addis Ababa, Ethiopia: A comparative cross-sectional study. HIV/AIDS—Research and Palliative Care 2019, 11:229–237.
View Article
Google Scholar

[98] View Article

[99] Google Scholar

[ref31] 31. Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A, et al: Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infectious Diseases 2019, 19(1):914. pmid:31664933
View Article
PubMed/NCBI
Google Scholar

[101] View Article

[102] PubMed/NCBI

[103] Google Scholar

[ref32] 32. Temesgen B, Kibret GD, Alamirew NM, Melkamu MW, Hibstie YT, Petrucka P, et al: Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: A retrospective record review. BMC Public Health 2019, 19(1):1566. pmid:31771552
View Article
PubMed/NCBI
Google Scholar

[105] View Article

[106] PubMed/NCBI

[107] Google Scholar

[ref33] 33. Solomon FB, Angore BN, Koyra HC, Tufa EG, Berheto TM, Admasu M: Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone Hospital: A retrospective study. BMC Research Notes 2018, 11(1):604. pmid:30126450
View Article
PubMed/NCBI
Google Scholar

[109] View Article

[110] PubMed/NCBI

[111] Google Scholar

[ref34] 34. Ali MS, Prieto-Alhambra D, Lopes LC, Ramos D, Bispo N, Ichihara MY, et al: Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances. Frontirs in Pharmacology 2019, 10:973.
View Article
Google Scholar

[113] View Article

[114] Google Scholar

[ref35] 35. Stuart EA, Lee BK, Leacy FP: Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. Journal of clinical epidemiology 2013, 66(8 Suppl):S84–S90.e81. pmid:23849158
View Article
PubMed/NCBI
Google Scholar

[116] View Article

[117] PubMed/NCBI

[118] Google Scholar

[ref36] 36. Rubin DB: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Statistics in Medicine 2007, 26(1):20–36. pmid:17072897
View Article
PubMed/NCBI
Google Scholar

[120] View Article

[121] PubMed/NCBI

[122] Google Scholar

[ref37] 37. Gedle D, Kumera G, Eshete T, Ketema K, Adugna H, Feyera F: Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia. Journal of Health, Population, and Nutrition 2017, 36(1):15. pmid:28506307
View Article
PubMed/NCBI
Google Scholar

[124] View Article

[125] PubMed/NCBI

[126] Google Scholar

[ref38] 38. Chen YN, Wall KM, Fofana K, Navarro-Colorado C: Nutrition indicators as potential predictors of AIDS-defining illnesses among ARV-naïve HIVpositive adults in Kapiri Mposhi, Zambia 2008–2009. PLoS ONE 2019, 14(7).
View Article
Google Scholar

[128] View Article

[129] Google Scholar

[ref39] 39. Katona P, Katona-Apte J: The interaction between nutrition and infection. Clin Infect Dis 2008, 46(10):1582–1588. pmid:18419494
View Article
PubMed/NCBI
Google Scholar

[131] View Article

[132] PubMed/NCBI

[133] Google Scholar

[ref40] 40. Bourke CD, Berkley JA, Prendergast AJ: Immune Dysfunction as a Cause and Consequence of Malnutrition. Trends Immunol 2016, 37(6):386–398. pmid:27237815
View Article
PubMed/NCBI
Google Scholar

[135] View Article

[136] PubMed/NCBI

[137] Google Scholar

[ref41] 41. Wan JM, Haw MP, Blackburn GL: Nutrition, immune function, and inflammation: an overview. Proc Nutr Soc 1989, 48(3):315–335. pmid:2515541
View Article
PubMed/NCBI
Google Scholar

[139] View Article

[140] PubMed/NCBI

[141] Google Scholar

[ref42] 42. Berhe N, Tegabu D, Alemayehu M: Effect of nutritional factors on adherence to antiretroviral therapy among HIV-infected adults: A case control study in Northern Ethiopia. BMC Infectious Diseases 2013, 13:233. pmid:23701864
View Article
PubMed/NCBI
Google Scholar

[143] View Article

[144] PubMed/NCBI

[145] Google Scholar

[ref43] 43. Young S, Wheeler AC, McCoy SI, Weiser SD: A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS and Behaviour 2014, 18 Suppl 5:S505–515. pmid:23842717
View Article
PubMed/NCBI
Google Scholar

[147] View Article

[148] PubMed/NCBI

[149] Google Scholar

[ref44] 44. Babo YD, Alemie GA, Fentaye FW: Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PLoS One 2017, 12(11):e0187694. pmid:29095936
View Article
PubMed/NCBI
Google Scholar

[151] View Article

[152] PubMed/NCBI

[153] Google Scholar

[ref45] 45. Ahmed M, Merga H, Jarso H: Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: A case-control study. BMC Infectious Diseases 2019, 19(1):305. pmid:30943903
View Article
PubMed/NCBI
Google Scholar

[155] View Article

[156] PubMed/NCBI

[157] Google Scholar

[ref46] 46. Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS: Predictors of time to first line antiretroviral treatment failure among adult patients living with HIV in public health facilities of Arba Minch Town, Southern Ethiopia. Ethiopian Journal of Health Sciences 2019, 29(2):175–186. pmid:31011265
View Article
PubMed/NCBI
Google Scholar

[159] View Article

[160] PubMed/NCBI

[161] Google Scholar

[ref47] 47. Bernard C, Balestre E, Coffie PA, Eholie SP, Messou E, Kwaghe V, et al: Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration. HIV AIDS (Auckl) 2018, 10:239–252. pmid:30532600
View Article
PubMed/NCBI
Google Scholar

[163] View Article

[164] PubMed/NCBI

[165] Google Scholar

[ref48] 48. Kalinjuma AV, Glass TR, Weisser M, Myeya SJ, Kasuga B, Kisung’a Y, et al: Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania. Journal of the International AIDS Society 2020, 23(3):e25460. pmid:32128998
View Article
PubMed/NCBI
Google Scholar

[167] View Article

[168] PubMed/NCBI

[169] Google Scholar

[ref49] 49. Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG, Yenit MK: Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: Retrospective follow up study. BMC Research Notes 2019, 12(1):111. pmid:30819236
View Article
PubMed/NCBI
Google Scholar

[171] View Article

[172] PubMed/NCBI

[173] Google Scholar

[ref50] 50. Teshome W, Belayneh M, Moges M, Mekonnen E, Endrias M, Ayele S, et al: Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in south Ethiopia? A retrospective follow-up study. HIV AIDS (Auckl) 2015, 7:167–174.
View Article
Google Scholar

[175] View Article

[176] Google Scholar

[ref51] 51. Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al: Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open 2013, 3(10):e003499. pmid:24163204
View Article
PubMed/NCBI
Google Scholar

[178] View Article

[179] PubMed/NCBI

[180] Google Scholar

[ref52] 52. Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al: Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS One 2018, 13(1):e0188488. pmid:29373574
View Article
PubMed/NCBI
Google Scholar

[182] View Article

[183] PubMed/NCBI

[184] Google Scholar

[ref53] 53. Tiruneh YM, Galárraga O, Genberg B, Wilson IB: Retention in Care among HIV-Infected Adults in Ethiopia, 2005–2011: A Mixed-Methods Study. PLoS One 2016, 11(6):e0156619. pmid:27272890
View Article
PubMed/NCBI
Google Scholar

[186] View Article

[187] PubMed/NCBI

[188] Google Scholar

[ref54] 54. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR: Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One 2010, 5(4):e10340. pmid:20442769
View Article
PubMed/NCBI
Google Scholar

[190] View Article

[191] PubMed/NCBI

[192] Google Scholar

[ref55] 55. World Health Organization: WHO global lists of high burden countries for tuberculosis (TB), TB/HIV and multidrug/rifampicin-resistant TB (MDR/RR-TB), 2021–2025: https://cdn.who.int/media/docs/default-source/hq-tuberculosis/who_globalhbcliststb_2021-2025_backgrounddocument.pdf?sfvrsn=f6b854c2_9. 2021.

[ref56] 56. World Health Organisation: HIV-Associated Tuberculosis https://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet.pdf?ua=1. 2018.

[ref57] 57. Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, et al: Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 2014, 370(26):2487–2498. pmid:24963568
View Article
PubMed/NCBI
Google Scholar

[196] View Article

[197] PubMed/NCBI

[198] Google Scholar

[ref58] 58. Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, et al: Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009, 51(2):130–134. pmid:19365271
View Article
PubMed/NCBI
Google Scholar

[200] View Article

[201] PubMed/NCBI

[202] Google Scholar

Figures

Abstract

Background

Methods

Results

Conclusion

Introduction

Methods

Study design, period, and setting

HIV care provision in the ART clinic

Study population

Sample size estimation and sampling

Data collection procedures

Study variables

Operational definitions

Missing data handling

Statistical analysis

Ethical considerations

Results

Sociodemographic characteristics of the cohort

Clinical characteristics of participants

Incidence of opportunistic infections

Checking balance on propensity scores

Checking balance on covariates

Effect of undernutrition on opportunistic infections

Discussion

Strengths and limitations of the study

Conclusion

Supporting information

S1 File. Data set used for this study.

Acknowledgments

References